Our finding of an inverse association between use of 3+ low-dose aspirin tablets/week and risk of breast cancer overall is consistent with the findings of several other observational studies that did not separately examine HR-defined and HER2-defined subtypes. Here, ERBB2 is linked to breast cancer.